Repatha
Product
A monoclonal antibody treatment for hypercholesterolemia that lowers LDL levels by blocking PCSK9.
Mentioned in 5 videos
Save the 5 videos on Repatha to your own pod.
Sign up free to keep building your knowledge base on Repatha as more episodes are added.
Videos Mentioning Repatha
#129 - Tom Dayspring, M.D.: The latest insights into cardiovascular disease and lipidology
Peter Attia MD
Another brand name for a PCSK9 inhibitor, also mentioned for its variable effect on Lp(a) reduction.
#23–Tom Dayspring Part IV of V: statins, Zetia, PCSK9 inhibitors, niacin, cholesterol & the brain
Peter Attia MD
A PCSK9 inhibitor developed by Amgen that demonstrated significant event reduction in the FOURIER trial, even in high-risk patients with already low LDL-C on statins.
Peter Diamandis and Tony Robbins on strategies that promote longevity now – and in the near future
FoundMyFitness
A monoclonal antibody treatment for hypercholesterolemia that lowers LDL levels by blocking PCSK9.
276 ‒ Special episode: Peter on longevity, supplements, protein, fasting, apoB, statins, & more
Peter Attia MD
210 - Lp(a) and its impact on heart disease | Benoît Arsenault, Ph.D.& Peter Attia, M.D.
Peter Attia MD
A PCSK9 inhibitor drug approved by the FDA based on its LDL-lowering effects.